Skip to main content
. 2021 Sep 20;12(11):2955–2969. doi: 10.1007/s13300-021-01151-6

Table 1.

Clinical characteristics

Total population Elderly patients (age ≥ 60 years) p value*
Sarcopenia Non-sarcopenia
Number 1042 141 350
Age 58.19 (57.41, 58.97) 71.33 (70.18, 72.47) 67.73 (67.11, 68.36) < 0.001
Gender (male %) 631 (60.56) 78 (55.32) 193 (55.14) 1.000
Drinking (%) 107 (10.27) 8 (5.67) 30 (8.57) 0.352
Current smoking (%) 203 (19.48) 12 (8.51) 57 (16.29) 0.031
Family history (%) 273 (26.20) 16 (11.35) 79 (22.57) 0.004
Diabetic duration (year) 7.67 (7.25, 8.09) 10.42 (9.08, 11.77) 9.77 (8.97, 10.57) 0.413
Height (cm) 165.39 (164.88, 165.89) 160.74 (159.51, 161.97) 164.31 (163.45, 165.17) < 0.001
Weight (kg) 68.17 (67.36, 68.97) 56.66 (55.28, 58.04) 68.09 (67.06, 69.13) < 0.001
BMI (kg/m2) 24.8 (24.58, 25.03) 21.9 (21.45, 22.36) 25.21 (24.88, 25.54) < 0.001
Waist to hip ratio 0.91 (0.91, 0.92) 0.9 (0.89, 0.91) 0.92 (0.91, 0.92) 0.001
Handgrip strength (kg) 26.23 (25.68, 26.77) 19.89 (18.79, 21) 24.68 (23.80, 25.56) < 0.001
Gait speed (m/s) 1.25 (1.24, 1.26) 1.08 (1.04, 1.12) 1.21 (1.19, 1.23) < 0.001
SMI (kg/m2) 7.09 (7.03, 7.16) 6.01 (5.89, 6.13) 7.11 (7.02, 7.20) < 0.001
Systolic pressure (mmHg) 128.51 (127.53, 129.48) 129.7 (127.15,132.26) 130.89 (129.2, 132.59) 0.686
Heart rate (/min) 77.11 (76.63, 77.59) 77.26 (75.31, 79.21) 76.20 (75.39, 77.00) 0.248
Albumin (g/L) 39.98 (39.76, 40.21) 38.79 (38.33, 39.25) 39.57 (39.17, 39.98) 0.011
ALT (U/L) 28.54 (27.2, 29.88) 24.45 (21.45, 27.45) 26.15 (24.17, 28.13) 0.066
AST (U/L) 20.04 (19.12, 20.96) 18.25 (16.57, 19.93) 19.71 (18.21, 21.21) 0.403
Total cholesterol (mmol/L) 4.49 (4.42, 4.56) 4.07 (3.89, 4.26) 4.37 (4.24, 4.49) 0.011
Triglyceride (mmol/L) 2.60 (1.90, 3.3) 1.48 (1.27, 1.68) 2.18 (1.50, 2.87) 0.010
LDL-c (mmol/L) 1.93 (1.89, 1.97) 1.67 (1.56, 1.78) 1.87 (1.80, 1.94) 0.002
HDL-c (mmol/L) 1.21 (1.19, 1.23) 1.27 (1.22, 1.33) 1.26 (1.21, 1.30) 0.244
Calcium (mmol/L) 2.27 (2.26, 2.28) 2.25 (2.23, 2.27) 2.27 (2.26, 2.28) 0.075
Phosphate (mmol/L) 1.19 (1.18, 1.20) 1.15 (1.12, 1.19) 1.16 (1.14, 1.18) 0.559
Creatinine (μmol/L) 67.70 (66.26, 69.14) 66.29 (61.95, 70.63) 71.25 (68.75, 73.74) 0.004
Uric acid (μmol/L) 309.44 (301.44, 317.45) 320.05 (278.21, 361.89) 314.61 (303.22, 325.99) 0.169
White blood cell (× 109) 6.00 (5.89, 6.11) 5.59 (5.21, 5.97) 6.03 (5.82, 6.23) 0.062
Red blood cell (× 1012) 4.42 (4.38, 4.45) 4.18 (4.10, 4.26) 4.34 (4.29, 4.40) 0.007
Hemoglobin (g/L) 137.02 (134.95,139.09) 129.21 (126.83, 131.59) 133.91 (132.11, 135.71) 0.003
FBG (mmol/L) 8.67 (8.41, 8.93) 8.14 (7.61,8.66) 8.49 (8.15,8.84) 0.257
PBG (mmol/L) 15.89 (15.36, 16.42) 15.17 (13.8,16.55) 16.28 (15.39, 17.17) 0.195
Fasting CP (ng/ml) 1.44 (1.38, 1.49) 1.4 (1.25, 1.55) 1.39 (1.30, 1.48) 0.978
CP-120 min (ng/ml) 3.83 (3.67, 4.00) 3.76 (3.34, 4.17) 3.76 (3.48, 4.04) 0.863
HbA1c (%) 9.03 (8.90, 9.15) 9.15 (8.75, 9.54) 9.09 (8.88, 9.3.0) 0.909
HOMA2-IR 3.85 (3.59, 4.11) 3.61 (3.17, 4.05) 3.58 (3.33, 3.83) 0.725
Hypertension (%) 540 (51.82) 89 (63.12) 237 (67.71) 0.343
Fatty liver (%) 414 (39.73) 23 (16.31) 124 (35.43) < 0.001
DKD (%) 132 (12.67) 20 (14.18) 50 (14.29) 1.000
Neuropathy (%) 221 (21.21) 42 (29.79) 80 (22.86) 0.133
Retinopathy (%) 245 (23.51) 30 (21.28) 97 (27.71) 0.171
Atherosclerosis (%) 510 (48.94) 121 (85.82) 280 (80.00) 0.156
Osteoporosis (%) 63 (6.05) 33 (23.40) 20 (5.71) < 0.001
Low bone mass (%) 204 (19.58) 49 (34.75) 88 (25.14) 0.035

BMI body mass index, SMI skeletal muscle index, ALT alanine transferase, AST aspartate transferase, LDL-c low density lipoprotein cholesterol, HDL-c high density lipoprotein cholesterol, FBG fasting blood glucose, PBG postprandial blood glucose, CP C-peptide, HbA1c hemoglobin, HOMA2-IR Homeostasis Model Assessment 2-Insulin Resistance, DKD diabetic kidney disease

*Sarcopenia vs. non-sarcopenia